2025, Number 4
<< Back Next >>
Rev Nefrol Dial Traspl 2025; 45 (4)
Infective endocarditis in hemodialysis
Casaliba AJ
Language: Spanish
References: 36
Page: 209-221
PDF size: 297.68 Kb.
ABSTRACT
Infective endocarditis is the disease
resulting from colonization of the
endocardium by virulent
microorganisms, with a wide range
of clinical manifestations and
posing challenges for internists
across diagnosis, treatment, and
prognosis. Patients on hemodialysis,
who suffer from early cardiovascular
and infectious diseases with high
prevalence, are particularly
susceptible to this complication.
Despite advances in diagnostic and
treatment methods, the prognosis
for patients with this complication
remains poor, with a mortality rate
ranging from 20% to 40%.
This review will analyze risk
factors, presentations, the most
commonly involved pathogens, and
diagnostic and therapeutic
approaches for the different clinical
presentations.
REFERENCES
Yallowitz AW; Decker LC.Infectious Endocarditis.National Library of Medicine StatPearls Publishing; 2025 Jan. Last Update: April 24, 2023.
Bacteremia in hemodialysis patients. Suzuki M,Satoh N, Nakamura M, Horita S, Seki G, Moriya K.World J Nephrol. 2016;5(6):489–96.
Ahmadmehrabi S, Tang WHW. Hemodialysisinducedcardiovascular disease. Semin Dial.2018;31(3):258–67.
Bashore TM, Cabell C, Fowler V Jr. Update oninfective endocarditis. Curr Probl Cardiol.2006;31(4):274–352.
Hubers SA, DeSimone DC, Gersh BJ, Anavekar NS.Infective endocarditis: a Contemporary Review.Mayo Clin Proc. 2020;95(5):982–97.
Infective Endocarditis in Patients on ChronicHemodialysis. Pericàs JM, MD, PHD, MPH, LlopisJ, MD, PHD, Exposito MJ, MD, PHD, Kourany WM,MD, Almirante B, MD, PHD, et al. Cardiol. 2021Apr 6;77(13):1629-1640.
Murdoch DR, Corey GR, Hoen B, Miró JM, FowlerVG, Bayer AS, et al. Investigadores del Estudio deCohorte Prospectivo de la Colaboración Internacionalsobre Endocarditis (ICE-PCS). Presentaciónclínica, etiología y pronóstico de la endocarditisinfecciosa en el siglo XXI: el Estudio de CohorteProspectivo de la Colaboración Internacionalsobre Endocarditis. Arch Intern Med. 9 de marzode 2009; 169 (5):463-73
López J, Olmos C, Fernández Hidalgo N. Novedadesen la endocarditis infecciosa. Revista Española deCardiología. 2024; 77(9):779-787
Casabé JH, Giunta G, Varini S, Barisani JL. Consensode Endocarditis Infecciosa. Versión resumida. RevARgent CARdiol 2016; 84:507-514.
Khaledi M, Sameni F, Afkhami M, Hemmati J,Zadegan Dezfuli AH, Validi M, et al. Endocarditisinfecciosa según HACEK: una revisión. Revista deCirugía Cardiotorácica volumen 17, Número deartículo: 185 (2022)
Hill EE, Herijgers P, Claus P, Vanderschueren S,Herregods MC, Peetermans WE. Endocarditisinfecciosa: cambios en la epidemiología ypredictores de mortalidad a los 6 meses: un estudiode cohorte prospectivo. Eur Heart J. Enero de 2007;28 (2):196-203.
Cabell CH, Jollis JG, Peterson GE, Corey GR,Anderson DJ, Sexton DJ, et al. Cambios en lascaracterísticas de los Pacientes y su Efecto Sobre laMortalidad en la Endocarditis. Arch Intern Med. 14de enero de 2002;162(1):90-4
Correa de Sa DD, Tleyjeh IM, Anavekar NS, SchultzJC, Thomas JM, Lahr BD, et al. Epidemiologicaltrends of infective endocarditis: a population-basedstudy in Olmsted County, Minnesota. Mayo ClinProc. 2010 May;85(5):422-6.
Abdulamir AS, Hafidh RR, Abu Bakar F. Theassociation of Streptococcus bovis/gallolyticus withcolorectal tumors: the nature and the underlyingmechanisms of its etiological role. J Exp Clin CancerRes. 2011 Jan 20;30(1):11
Ernesto Ferreiros, Francisco Nacinovich, JoseHoracio Casabé, Juan Carlos Modenesi, SanDra.Swieszkowski, Claudia Cortes, et al. EIRA-2Investigators. Epidemiologic, clinical, andmicrobiologic profile of infective endocarditis inArgentina: a national survey. The EndocarditisInfecciosa en la República Argentina-2 (EIRA-2)Study Am Heart J. 2006 Feb;151(2):545-52.
Casabé JH. Infective endocarditis. A changingdisease. Medicina (B Aires). 2008;68(2):164-74.
Ding U, Ooi L, Wu HHL, Chinnadurai R.Infective Endocarditis in Patients ReceivingHemodialysis: A Current Review. Kidney Dis(Basel). 2024 Jul 26;10(6):519–530.
Y Bentata, I Haloui, I Haddiya, A Benzirar, O ElMahi, N Ismailli, N Elouafi. Infective endocarditis inhemodialysis patients: A 10-year observational singlecenter study. J Vasc Access. 2022 Jan;23(1):149-153.
Cahill TJ, Prendergast BD. Endocarditis infecciosa.The Lancet. 27 de febrero de 2016; 387 (10021):882-93
Lazarus JM, Denker BM, Owen FO Jr, in TheKidney Fifth Ed. Brenner and Rector p. 2463
Umana E, Ahmed W, Alpert MA. Valvular andperivalvular abnormalities in end-stage renal disease.Am J Med Sci. 2003 Apr; 325(4):237-42.
Stefaan J Vandecasteele, Johan R Boelaert, An S DeVrieseClin. Staphylococcus aureus infections inhemodialysis: what a nephrologist should know. JAm Soc Nephrol. 2009 Aug;4(8):1388-400.
Usuku H, Yamamoto E, Arima Y, Takashio S, ArakiS, Sueta D, et al.Accumulation of coronary riskfactors is associated with progression of mitralannular calcification in patients undergoing dialysistherapy: A long-term follow-up study. Int J Cardiol.2019 Oct 15:293:248-253.
San Román JA, Vilacosta I, López J, Revilla A,Arnold R, Sevilla T, et al. Role of Transthoracic andTransesophageal Echocardiography in Right-SidedEndocarditis: One Echocardiographic Modality DoesNot Fit All. JASE. 2012; 25(8):807-814
25.) J A San Román, I Vilacosta, J L Zamorano, CAlmería, L Sánchez-Harguindey.Transesophagealechocardiography in right-sided endocarditis. J AmColl Cardiol. 1993 Apr;21(5):1226-30.
Issa R, Chaaban N, Salahie A, Honnekeri B, ZarizherG, Xu B. Infective Endocarditis in Patients with End-Stage Renal Disease on Dialysis: Epidemiology, RiskFactors, Diagnostic Challenges, and ManagementApproaches. Healthcare 2024, 12(16):1631
Sadeghi M, Behdad S, Shahsanaei F. InfectiveEndocarditis and Its Short and Long-Term Prognosisin Hemodialysis Patients: A Systematic Review andMeta-analysis. Curr Probl Cardiol. 2021Mar;46(3):100680.
Li JS, Sexton DJ,Mick N, Nettles R, Fowler Jr VG,Ryan T, et al. Proposed modifications to the Dukecriteria for the diagnosis of infective endocarditisClin Infect Dis. 2000 Apr; 30(4):633-8.
Fowler Jr VG, Durack DT, Selton-Suty C, Athan E,Bayer AS, Chamis AL, et al. The 2023 Duke-International Society for Cardiovascular InfectiousDiseases Criteria for Infective Endocarditis: Updatingthe Modified Duke Criteria Clin Infect Dis. 2023May 4;77(4):518–526.
Fu Chang C, Ing-Tiau Kuo B, Chen TL, Wu-ChangY, Dong Lee S, Chih-Ching L. Infective endocarditisin maintenance hemodialysis patients: fifteen years’experience in one medical center. J Nephrol. 2004Mar-Apr; 17(2):228-35.
Kaufmann CC, Wessely E, Huber K. Endocarditistrombótica no bacteriana en el contexto deadenocarcinoma pulmonar: reporte de un caso. EurHeart J Case Rep. Febrero de 2020; 4 (1):1-5.
Iung, B, Doco-Lecompte T, Chocron, S, Strady, C,Delahaye, F, Le Moing V, et al. Cardiac surgeryduring the acute phase of infective endocarditis:Discrepancies between European Society ofCardiology guidelines and practices. Eur. Heart J.2016, 37:840–848.
Gatti G, Fiore A, Ismail M, Dra.lov A, Saade W,Costantino V, et al. Prediction of 30-day mortalityafter surgery for infective endocarditis using riskscores: Insights from a European multicentercomparative validation study. Am. Heart J. 2024,275, 108–118
Kamalakannan D, Pai RM, Johnson LB, Gardin JM,Saravolatz LD. Epidemiology and clinical outcomesof infective endocarditis in hemodialysis patients.Ann Thorac Surg. 2007;83(6):2081–6.
Bhatia N, Agrawal S, Garg A, Mohananey D,Sharma A, Agarwal M, et al. Trends and outcomes ofinfective endocarditis in patients on dialysis. ClinCardiol. 2017 Jul;40(7):423-429.
Luehr M, Bauernschmitt N, Peters S, Li Y, Heyn O,Dashkevich A, et al. Incidence and SurgicalOutcomes of Patients with Native and ProstheticAortic Valve Endocarditis. Ann Thorac Surg. 2020Jul;110(1):93-101.